Search results
Results from the WOW.Com Content Network
The pharmaceutical industry in Canada employs approximately 30,000 people. It supplies about one third of the domestic pharmaceutical consumer market of $27 billion annually. [1] This accounts for ~16% of yearly health expenditures. Canada had a pharmaceutical trade deficit of $8.5 billion in 2018 with exports of $11 billion and imports of $19. ...
Doxazosin, sold under the brand name Cardura among others, is a medication used to treat symptoms of benign prostatic hyperplasia (enlarged prostate), hypertension (high blood pressure), and post-traumatic stress disorder (PTSD). [1] [2] For high blood pressure, it is a less preferred option. [2] It is taken by mouth. [2]
Pages in category "Pharmaceutical companies of Canada" The following 24 pages are in this category, out of 24 total. This list may not reflect recent changes .
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding CA$2.5 billion. [5] By 2023, Apotex employed close to 8,000 people as Canada's largest drug manufacturer, with over 300 products selling in over 115 countries.
The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC ...
Canada is the world's eighth-largest economy as of 2022, with a nominal GDP of approximately US$2.2 trillion. [1] It is a member of the Organisation for Economic Co-operation and Development (OECD) and the Group of Seven (G7), and is one of the world's top ten trading nations , with a highly globalized economy.
Canada’s Health Research Foundation (HRF) is a non-profit organization that invests in health research in Canadian academic centres, and promotes the benefits and values of research-driven health innovation in Canada. Innovative Medicines Canada members pay an annual contribution of $1 million to the Foundation. [17]